TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P20
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -15.39% |
| 2024 | -40.71% |
| 2023 | 39.69% |
| 2022 | 50.15% |
| 2021 | 0.00% |
| 2020 | 0.00% |